Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau

Lancet

Volumn 359, Issue 9314, 2002, Pages 1313-1314

  Benn, Christine Stabell ^a,b   Balde, Aliu ^a,b   George, Elisha ^c   Kidd, Michael ^c   Whittle, Hilton ^c   Lisse, Ida Marie ^a,b   Aaby, Peter ^a,b  

^a Projecto de Saude de Bandim   (Guinea-Bissau)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE; PLACEBO; RETINOL;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GUINEA-BISSAU; HUMAN; INFECTION RISK; MALE; MEASLES; PRIORITY JOURNAL; RETINOL DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 0037070796     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08274-0     Document Type: Article

References (5)

1. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa
2. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines
3. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal
4. Measles antibody: Reevaluation of protective titers